• Sunovion Divests Asthma and Allergy Products to Covis americanpharmaceuticalreview
    July 18, 2017
    Sunovion has entered into a definitive agreement to divest the U.S. market rights to Sunovion’s ciclesonide products ALVESCO Inhalation Aerosol, OMNARIS Nasal Spray, and ZETONNA Nasal Aerosol to Covis Pharma. Ciclesonides are included in the corticosteroi
PharmaSources Customer Service